Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study
Gülçin Şahingöz Erdal, Özlem Polat, Gökmen Umut Erdem, et al.
International Journal of Clinical Oncology (2021) Vol. 26, Iss. 5, pp. 826-834
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer
Mariana Chávez‐MacGregor, Xiudong Lei, Hui Zhao, et al.
JAMA Oncology (2021) Vol. 8, Iss. 1, pp. 69-69
Open Access | Times Cited: 193
Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer
Emma G Khoury, Sarah J Nevitt, William Rohde Madsen, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2210880-e2210880
Open Access | Times Cited: 73
Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis
Marco Tagliamento, Elisa Agostinetto, Marco Bruzzone, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 163, pp. 103365-103365
Open Access | Times Cited: 60
Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies
Ronit Gurion, Uri Rozovski, Gilad Itchaki, et al.
Haematologica (2021) Vol. 107, Iss. 3, pp. 715-720
Open Access | Times Cited: 54
COVID ‐19 in cancer patients may be presented by atypical symptoms and higher mortality rate, a case‐controlled study from Iran
Soodabeh Shahidsales, Seyed Amir Aledavood, Mona Joudi, et al.
Cancer Reports (2021) Vol. 4, Iss. 5
Open Access | Times Cited: 42
Telehealth Preferences Among Patients With Advanced Cancer in the Post COVID-19 Vaccine Era
Kaoswi Karina Shih, Adrienne B Arechiga, Xi Chen, et al.
Journal of Pain and Symptom Management (2024) Vol. 67, Iss. 6, pp. 525-534.e1
Closed Access | Times Cited: 5
Navigating Equitable Access to Cancer and Mental Health Services During Pandemics: Stakeholder Perspectives on COVID-19 Challenges and Community-Based Solutions for Immigrants and Refugees—Proceedings from Think Tank Sessions
Mandana Vahabi, Kimberly Devotta, Cliff Ledwos, et al.
Healthcare (2025) Vol. 13, Iss. 5, pp. 564-564
Open Access
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients
Mehmet Emin Arayıcı, Nazlican Kipcak, Ufuktan Kayacik, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 2915-2928
Open Access | Times Cited: 22
Cancer Patients during COVID-19 Pandemic: A Mini-Review
Maryam Linjawi, Hira Shakoor, Serene Hilary, et al.
Healthcare (2023) Vol. 11, Iss. 2, pp. 248-248
Open Access | Times Cited: 14
Association of the COVID-19 Pandemic and Changes in Patterns of Cancer-Related Mortality in the United States
Jingxuan Zhao, Xuesong Han, Kimberly D. Miller, et al.
JCO Oncology Practice (2023) Vol. 19, Iss. 7, pp. 501-508
Closed Access | Times Cited: 12
Comparative assessment of 9-bromo noscapine ionic liquid and noscapine: Synthesis, in-vitro studies plus computational & biophysical evaluation with human hemoglobin
Shubham Sewariya, Hitesh Sehrawat, Nistha Mishra, et al.
International Journal of Biological Macromolecules (2023) Vol. 247, pp. 125791-125791
Closed Access | Times Cited: 12
The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials
Jennyfa Kadiza Ali, John C. Riches
Cancers (2021) Vol. 13, Iss. 23, pp. 5924-5924
Open Access | Times Cited: 30
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups
Hans‐Georg Rammensee, Cécile Gouttefangeas, Sonja Heidu, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 428-428
Open Access | Times Cited: 28
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab
Erica Franceschini, Mariachiara Pellegrino, Vera Todisco, et al.
Infection (2023) Vol. 51, Iss. 5, pp. 1577-1581
Open Access | Times Cited: 10
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis
Haig Pakhchanian, Hiba Khan, Rahul Raiker, et al.
Seminars in Arthritis and Rheumatism (2022) Vol. 56, pp. 152034-152034
Open Access | Times Cited: 15
COVID-19 in cancer patients
Suranjith L. Seneviratne, Widuranga Wijerathne, Pamodh Yasawardene, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2022) Vol. 116, Iss. 9, pp. 767-797
Open Access | Times Cited: 13
Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection
DF Bavaro, Lucia Diella, Antonio Giovanni Solimando, et al.
Pathogens and Global Health (2022) Vol. 116, Iss. 5, pp. 297-304
Open Access | Times Cited: 10
Determinants of COVID-19 cases and deaths in OECD countries
Burak Tekerek, Meliha Meliş GÜNALTAY, Gökçen ÖZLER, et al.
Journal of Public Health (2023) Vol. 32, Iss. 3, pp. 473-484
Open Access | Times Cited: 5
Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis
Linlin Wang, Ye Wang, Xianbin Cheng, et al.
Translational Oncology (2022) Vol. 28, pp. 101605-101605
Open Access | Times Cited: 8
Clinical characteristics, risk factors and outcomes of cancer patients withCOVID‐19: A population‐based study
Jiandong Zhou, Ishan Lakhani, Oscar Hou In Chou, et al.
Cancer Medicine (2022) Vol. 12, Iss. 1, pp. 287-296
Open Access | Times Cited: 7
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: A systematic review with meta-analysis involving 709.908 participants and 31.732 cancer patients
Mehmet Emin Arayıcı, Nazlican Kipcak, Ufuktan Kayacik, et al.
Research Square (Research Square) (2022)
Closed Access | Times Cited: 7
Dynamic Management of Lung Cancer Care During Surging COVID-19
Annie Wang, Stephanie H. Chang, Eric J. Kim, et al.
Frontiers in Surgery (2021) Vol. 8
Open Access | Times Cited: 10
At the heart of the COVID‐19 crisis: Perceived concerns of changes in long‐term cancer care in French women with cancer
Claire Della Vecchia, Magali Girodet, Stéphéline Ginguené, et al.
European Journal of Cancer Care (2022) Vol. 31, Iss. 4
Open Access | Times Cited: 6
Postvaccine Era COVID-19 Pandemic-Related Distress in Palliative Care Patients With Advanced Cancer
Kaoswi Karina Shih, Adrienne B Arechiga, Xi Chen, et al.
Journal of Pain and Symptom Management (2023) Vol. 66, Iss. 4, pp. 328-337.e2
Open Access | Times Cited: 3
The impact of COVID‐19 on mortality, length of stay, and cost of care among patients with gastrointestinal malignancies: A propensity score‐matched analysis
Mark B. Ulanja, Bryce D. Beutler, Kwabena O. Asafo-Agyei, et al.
Cancer Medicine (2023) Vol. 12, Iss. 16, pp. 17365-17376
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top